| C517113 | 1,1-bis(4-hydroxyphenyl)cyclohexane | "1,1-bis(4-hydroxyphenyl)cyclohexane results in decreased expression of TFPI mRNA" | 28591870 |
| C026486 | 1,2,5,6-dibenzanthracene | "1,2,5,6-dibenzanthracene results in increased expression of TFPI mRNA" | 26377693 |
| C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of TFPI mRNA" | 19114083 |
| C029497 | 2,3-bis(3'-hydroxybenzyl)butyrolactone | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFPI mRNA" | 19167446 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in decreased expression of TFPI mRNA" | 18648102 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFPI mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFPI mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of TFPI mRNA | 21420995|2906747 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of TFPI mRNA | 17585979 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of TFPI gene | 27153756 |
| D000447 | Aldehydes | Aldehydes results in decreased expression of TFPI mRNA | 25014914 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of TFPI mRNA | 16483693 |
| D000661 | Amphetamine | Amphetamine results in decreased expression of TFPI protein | 20118172 |
| D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of TFPI mRNA" | 18687144 |
| C487081 | belinostat | belinostat results in increased expression of TFPI mRNA | 26272509 |
| C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| D001554 | Benzene | Benzene results in decreased expression of TFPI mRNA | 15929907 |
| C006703 | benzo(b)fluoranthene | benzo(b)fluoranthene results in increased expression of TFPI mRNA | 26377693 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of TFPI mRNA | 22316170 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of TFPI mRNA | 19770486 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TFPI mRNA" | 20018196 |
| D004958 | Estradiol | EGF protein inhibits the reaction [Estradiol results in decreased expression of TFPI mRNA] | 24758408 |
| D004958 | Estradiol | Estradiol affects the expression of TFPI mRNA | 22574217 |
| D004958 | Estradiol | [Estradiol co-treated with Progesterone] results in decreased expression of TFPI mRNA | 20660070 |
| D004958 | Estradiol | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TFPI mRNA | 19619570 |
| D004958 | Estradiol | Estradiol results in decreased expression of and results in decreased secretion of TFPI protein | 17029634 |
| D004958 | Estradiol | Estradiol results in decreased expression of TFPI mRNA | 21185374|2475840 |
| D004958 | Estradiol | Estradiol results in increased expression of TFPI mRNA | 19619570 |
| C543008 | bis(4-hydroxyphenyl)sulfone | bis(4-hydroxyphenyl)sulfone results in decreased expression of TFPI mRNA | 28591870 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of TFPI mRNA | 28711546 |
| C006780 | bisphenol A | bisphenol A results in increased expression of TFPI mRNA | 22687993 |
| C006780 | bisphenol A | bisphenol A results in increased expression of TFPI mRNA | 25181051 |
| D002066 | Busulfan | Busulfan results in decreased expression of TFPI mRNA | 22286157 |
| C018475 | butyraldehyde | butyraldehyde results in decreased expression of TFPI mRNA | 26079696 |
| C584509 | C646 compound | C646 compound results in increased expression of TFPI mRNA | 26191083 |
| C043211 | carvedilol | [irbesartan co-treated with carvedilol] results in decreased expression of TFPI mRNA | 21229253 |
| C043211 | carvedilol | [irbesartan co-treated with carvedilol] results in decreased expression of TFPI protein | 21229253 |
| D020245 | p-Chloromercuribenzoic Acid | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| D020245 | p-Chloromercuribenzoic Acid | p-Chloromercuribenzoic Acid results in increased expression of TFPI mRNA | 26272509 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion results in increased expression of TFPI protein | 28596144 |
| D002994 | Clofibrate | Clofibrate results in decreased expression of TFPI mRNA | 16081524 |
| D002995 | Clofibric Acid | Clofibric Acid affects the expression of TFPI mRNA | 17602206 |
| D002995 | Clofibric Acid | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TFPI mRNA | 17602206 |
| D002996 | Clomiphene | Clomiphene results in increased expression of TFPI mRNA | 26865669 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of TFPI mRNA | 24386269 |
| D003300 | Copper | [NSC 689534 binds to Copper] which results in increased expression of TFPI mRNA | 20971185 |
| D019327 | Copper Sulfate | Copper Sulfate affects the expression of TFPI mRNA | 19549813 |
| D003375 | Coumestrol | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFPI mRNA" | 19167446 |
| D003471 | Cuprizone | Cuprizone results in decreased expression of TFPI mRNA | 27523638 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of TFPI mRNA | 20106945|2556210 |
| D003561 | Cytarabine | Cytarabine results in decreased expression of TFPI mRNA | 21198554 |
| D003703 | Demecolcine | Demecolcine results in increased expression of TFPI mRNA | 23649840 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of TFPI mRNA | 25047013 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of TFPI mRNA | 21266533 |
| D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in decreased expression of TFPI mRNA | 27392435 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of TFPI mRNA | 27392435 |
| C000944 | dicrotophos | dicrotophos results in decreased expression of TFPI mRNA | 28302478 |
| D004041 | Dietary Fats | [Dietary Fats co-treated with resveratrol] results in increased expression of TFPI mRNA | 21852083 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TFPI mRNA | 17602206 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in decreased expression of TFPI mRNA | 26865669 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of TFPI mRNA | 21658437 |
| D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide affects the expression of TFPI mRNA | 24834073 |
| D004237 | Diuron | Diuron results in increased expression of TFPI mRNA | 21551480|2515243 |
| D004317 | Doxorubicin | TFPI protein affects the susceptibility to Doxorubicin | 16217747 |
| D004966 | Estrogens, Conjugated (USP) | "Estrogens, Conjugated (USP) affects the expression of TFPI mRNA" | 15964915 |
| D004970 | Estrone | Estrone results in decreased expression of TFPI mRNA | 26865669 |
| D000431 | Ethanol | Ethanol results in decreased expression of TFPI mRNA | 28986285 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of and results in decreased secretion of TFPI protein | 17029634 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased activity of TFPI protein | 15857755 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of TFPI mRNA | 17557909 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of TFPI protein | 15857755 |
| D004997 | Ethinyl Estradiol | fulvestrant inhibits the reaction [Ethinyl Estradiol results in decreased activity of TFPI protein] | 15857755 |
| D004997 | Ethinyl Estradiol | norethindrone acetate promotes the reaction [Ethinyl Estradiol results in decreased activity of TFPI protein] | 15857755 |
| D008656 | Mestranol | Mestranol results in decreased expression of TFPI mRNA | 26865669 |
| C024565 | ethylene dichloride | ethylene dichloride results in decreased expression of TFPI mRNA | 28189721 |
| D005047 | Etoposide | TFPI protein affects the susceptibility to Etoposide | 16217747 |
| D005472 | Fluorouracil | TFPI protein affects the susceptibility to Fluorouracil | 16217747 |
| C065180 | fluvastatin | fluvastatin results in increased expression of TFPI protein | 16142594 |
| D005557 | Formaldehyde | Formaldehyde results in increased expression of TFPI mRNA | 23649840 |
| C070081 | fulvestrant | [fulvestrant co-treated with Raloxifene Hydrochloride] results in increased secretion of TFPI protein | 17029634 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in decreased expression of and results in decreased secretion of TFPI protein] | 17029634 |
| C070081 | fulvestrant | fulvestrant results in decreased secretion of TFPI protein | 17029634 |
| C070081 | fulvestrant | fulvestrant results in increased expression of TFPI mRNA | 26865669 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Ethinyl Estradiol results in decreased activity of TFPI protein] | 15857755 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [norethindrone acetate results in decreased activity of TFPI protein] | 15857755 |
| C001277 | geldanamycin | geldanamycin results in increased expression of TFPI mRNA | 26705709 |
| D019833 | Genistein | Genistein results in decreased expression of TFPI mRNA | 18847459|2686566 |
| D019833 | Genistein | Genistein results in increased expression of TFPI mRNA | 17341692 |
| D006589 | Hexestrol | Hexestrol results in decreased expression of TFPI mRNA | 26865669 |
| D017313 | Fenretinide | Fenretinide results in decreased expression of TFPI mRNA | 28973697 |
| C492448 | ICG 001 | ICG 001 results in increased expression of TFPI mRNA | 26191083 |
| C016517 | indole-3-carbinol | indole-3-carbinol affects the expression of TFPI mRNA | 21396975 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TFPI mRNA | 25613284 |
| C081309 | irbesartan | [irbesartan co-treated with carvedilol] results in decreased expression of TFPI mRNA | 21229253 |
| C081309 | irbesartan | [irbesartan co-treated with carvedilol] results in decreased expression of TFPI protein | 21229253 |
| C051890 | irinotecan | irinotecan analog results in decreased expression of TFPI mRNA | 18927307 |
| C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in decreased expression of TFPI mRNA | 27392435 |
| C544151 | jinfukang | jinfukang results in decreased expression of TFPI mRNA | 27392435 |
| C098607 | JP8 aviation fuel | JP8 aviation fuel results in increased expression of TFPI protein | 17337753 |
| C561695 | (+)-JQ1 compound | [(+)-JQ1 compound co-treated with PD 0325901] results in decreased expression of TFPI mRNA | 25119042 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of TFPI mRNA | 24796395|2511904 |
| D007854 | Lead | Lead affects the expression of TFPI mRNA | 28903495 |
| D017258 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate results in increased expression of TFPI mRNA | 20843944 |
| C042720 | mercuric bromide | mercuric bromide results in increased expression of TFPI mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of TFPI mRNA | 23179753|2800136 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of TFPI mRNA | 23179753|2627250 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of TFPI mRNA" | 26251327 |
| D016685 | Mitomycin | TFPI protein affects the susceptibility to Mitomycin | 16217747 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased expression of TFPI mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of TFPI mRNA" | 25554681 |
| C024262 | norethindrone acetate | fulvestrant inhibits the reaction [norethindrone acetate results in decreased activity of TFPI protein] | 15857755 |
| C024262 | norethindrone acetate | norethindrone acetate promotes the reaction [Ethinyl Estradiol results in decreased activity of TFPI protein] | 15857755 |
| C024262 | norethindrone acetate | norethindrone acetate results in decreased activity of TFPI protein | 15857755 |
| C024262 | norethindrone acetate | norethindrone acetate results in decreased expression of TFPI protein | 15857755 |
| C558013 | NSC 689534 | [NSC 689534 binds to Copper] which results in increased expression of TFPI mRNA | 20971185 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of TFPI mRNA | 26272509 |
| C506614 | PD 0325901 | [(+)-JQ1 compound co-treated with PD 0325901] results in decreased expression of TFPI mRNA | 25119042 |
| C506614 | PD 0325901 | PD 0325901 results in decreased expression of TFPI mRNA | 25119042 |
| C046012 | pentanal | pentanal results in decreased expression of TFPI mRNA | 26079696 |
| D010426 | Pentosan Sulfuric Polyester | Pentosan Sulfuric Polyester results in increased expression of TFPI mRNA | 28973697 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of TFPI mRNA | 19159669 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of TFPI mRNA | 26272509 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of TFPI mRNA | 19162173 |
| D010938 | Plant Oils | Plant Oils results in increased expression of TFPI mRNA | 23370395 |
| C054694 | polyoxyethyleneamine | polyoxyethyleneamine results in decreased expression of TFPI mRNA | 28711546 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of TFPI mRNA | 22714537 |
| D011374 | Progesterone | [Estradiol co-treated with Progesterone] results in decreased expression of TFPI mRNA | 20660070 |
| C005556 | propionaldehyde | propionaldehyde results in decreased expression of TFPI mRNA | 26079696 |
| D011441 | Propylthiouracil | Propylthiouracil results in decreased expression of TFPI mRNA | 24780913 |
| D011794 | Quercetin | Quercetin results in decreased expression of TFPI mRNA | 21632981 |
| D020849 | Raloxifene Hydrochloride | [fulvestrant co-treated with Raloxifene Hydrochloride] results in increased secretion of TFPI protein | 17029634 |
| D020849 | Raloxifene Hydrochloride | fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in decreased expression of and results in decreased secretion of TFPI protein] | 17029634 |
| D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride results in decreased expression of and results in decreased secretion of TFPI protein | 17029634 |
| D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride results in increased expression of TFPI mRNA | 26865669 |
| C059514 | resveratrol | [Dietary Fats co-treated with resveratrol] results in increased expression of TFPI mRNA | 21852083 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog affects the expression of TFPI mRNA | 25895662 |
| D012834 | Silver | Silver results in decreased expression of TFPI mRNA | 27131904 |
| D012906 | Smoke | Smoke results in increased expression of TFPI mRNA | 21095227 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of TFPI mRNA | 19072884 |
| D013629 | Tamoxifen | Tamoxifen results in decreased expression of and results in decreased secretion of TFPI protein | 17029634 |
| D013739 | Testosterone | Testosterone results in increased expression of TFPI | 20442653 |
| D013749 | Tetrachlorodibenzodioxin | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TFPI mRNA | 19619570 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of TFPI mRNA | 20106945|2163298 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of TFPI mRNA | 19619570 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TFPI mRNA | 25613284 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of TFPI mRNA | 28065790 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of TFPI mRNA | 18087596 |
| D019772 | Topotecan | TFPI protein affects the susceptibility to Topotecan | 16217747 |
| D014212 | Tretinoin | Tretinoin results in increased expression of TFPI mRNA | 21934132 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of TFPI mRNA | 24935251|2627250 |
| C015559 | trimellitic anhydride | trimellitic anhydride results in decreased expression of TFPI mRNA | 19042947 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in increased expression of TFPI mRNA" | 26179874 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFPI mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of TFPI mRNA | 23179753|2627250 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of TFPI mRNA | 24383497|2493525 |
| D014638 | Vanadates | Vanadates results in increased expression of TFPI mRNA | 22714537 |
| D014750 | Vincristine | Vincristine results in increased expression of TFPI mRNA | 23649840 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in increased expression of TFPI mRNA | 26272509 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of TFPI mRNA | 24714768 |